Literature DB >> 16771254

Intraperitoneal sodium thiosulfate for the treatment of calciphylaxis.

Danijela Mataic1, Bahar Bastani.   

Abstract

Calcific uremic arteriolopathy (or calciphylaxis) is a severe complication of renal failure characterized by subcutaneous calcification of the small arteries and tissue necrosis. We describe the case of a woman receiving continuous cycling peritoneal dialysis with calciphylaxis involving upper and lower extremities. After intolerance of intravenous sodium thiosulfate and limited intravenous access options, we administered sodium thiosulfate intraperitoneally and quantitated the amount of extra calcium removed. Intraperitoneal administration of sodium thiosulfate was well tolerated and led to removal of extra calcium with peritoneal dialysis.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16771254     DOI: 10.1080/08860220600583781

Source DB:  PubMed          Journal:  Ren Fail        ISSN: 0886-022X            Impact factor:   2.606


  18 in total

1.  Chemical peritonitis after intraperitoneal sodium thiosulfate.

Authors:  D R Gupta; H Sangha; R Khanna
Journal:  Perit Dial Int       Date:  2012 Mar-Apr       Impact factor: 1.756

2.  Painful skin ulcers in a hemodialysis patient.

Authors:  Stuart M Sprague
Journal:  Clin J Am Soc Nephrol       Date:  2013-11-07       Impact factor: 8.237

Review 3.  Vascular calcification in chronic kidney disease: Pathogenesis and clinical implication.

Authors:  Sinee Disthabanchong
Journal:  World J Nephrol       Date:  2012-04-06

4.  Sodium thiosulfate pharmacokinetics in hemodialysis patients and healthy volunteers.

Authors:  Stefan Farese; Emilie Stauffer; Robert Kalicki; Tatjana Hildebrandt; Brigitte M Frey; Felix J Frey; Dominik E Uehlinger; Andreas Pasch
Journal:  Clin J Am Soc Nephrol       Date:  2011-05-12       Impact factor: 8.237

5.  Simulation-based sodium thiosulfate dosing strategies for the treatment of calciphylaxis.

Authors:  Rajendra Pratap Singh; Hartmut Derendorf; Edward A Ross
Journal:  Clin J Am Soc Nephrol       Date:  2011-03-24       Impact factor: 8.237

6.  Lowering vascular calcification burden in chronic kidney disease: Is it possible?

Authors:  Sinee Disthabanchong
Journal:  World J Nephrol       Date:  2013-08-06

Review 7.  Calcific uremic arteriolopathy: pathophysiology, reactive oxygen species and therapeutic approaches.

Authors:  Kurt M Sowers; Melvin R Hayden
Journal:  Oxid Med Cell Longev       Date:  2010 Mar-Apr       Impact factor: 6.543

Review 8.  Sodium thiosulfate in the treatment of calcific uremic arteriolopathy.

Authors:  Georg Schlieper; Vincent Brandenburg; Markus Ketteler; Jürgen Floege
Journal:  Nat Rev Nephrol       Date:  2009-09       Impact factor: 28.314

Review 9.  Calciphylaxis: calcific uremic arteriolopathy and the emerging role of sodium thiosulfate.

Authors:  Melvin R Hayden; David Goldsmith; James R Sowers; Ramesh Khanna
Journal:  Int Urol Nephrol       Date:  2008       Impact factor: 2.370

Review 10.  Calcific uremic arteriolopathy in end stage renal disease: pathophysiology and management.

Authors:  Preethi Yerram; Kunal Chaudhary
Journal:  Ochsner J       Date:  2014
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.